Native Bordetella pertussis Filamentous Hemagglutinin protein
Be the first to review this product! Submit a review
|
(0 Publication)
Native Bordetella pertussis Filamentous Hemagglutinin protein is a Bordetella pertussis Tohama I protein, suitable for SDS-PAGE, ELISA.
View Alternative Names
BP1879, fhaB, Filamentous hemagglutinin
- SDS-PAGE
Supplier Data
SDS-PAGE - Native Bordetella pertussis Filamentous Hemagglutinin protein (AB274654)
SDS-PAGE of ab274654.
Reactivity data
Product details
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FHA facilitates attachment to ciliated epithelial cells in the human respiratory system enabling Bordetella pertussis to establish infection. This interaction allows the bacterium to evade immune responses effectively. FHA acts as a critical component of the bacterial adherence complex working together with other virulence factors like pertussis toxin and fimbriae. This combination of proteins enhances the bacterium’s ability to persist within host tissues.
Pathways
The fibronectin-binding property of FHA plays an important role in the process of bacterial adherence and colonization pathways. FHA works synergistically with other bacterial proteins like pertactin engaging in crosstalk that affects the modulation of immune pathways in the host. These pathways are important for the competitive advantage of Bordetella pertussis within the respiratory tract facilitating infection and immune evasion.
Specifications
Form
Liquid
Additional notes
This product is highly purified from Bordetella pertussis culture supernatant.
General info
Function
Evidence for a role in host-cell binding and infection.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com